Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Gadoterate Meglumine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 543Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Magnescope, Meglumine gadoterate (jan), Gadoterate meglumine (usan), Gadoterate meglumine [usan], Meglumine gadoterate [jan], Magnescope (tn)
    Molecular Formula
    C23H42GdN5O13
    Molecular Weight
    753.9  g/mol
    InChI Key
    RYHQMKVRYNEBNJ-BMWGJIJESA-K
    FDA UNII
    L0ND3981AG
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-[4,7-bis(carboxylatomethyl)-10-(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+);(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
    2.1.2 InChI
    InChI=1S/C16H28N4O8.C7H17NO5.Gd/c21-13(22)9-17-1-2-18(10-14(23)24)5-6-20(12-16(27)28)8-7-19(4-3-17)11-15(25)26;1-8-2-4(10)6(12)7(13)5(11)3-9;/h1-12H2,(H,21,22)(H,23,24)(H,25,26)(H,27,28);4-13H,2-3H2,1H3;/q;;+3/p-3/t;4-,5+,6+,7+;/m.0./s1
    2.1.3 InChI Key
    RYHQMKVRYNEBNJ-BMWGJIJESA-K
    2.1.4 Canonical SMILES
    CNCC(C(C(C(CO)O)O)O)O.C1CN(CCN(CCN(CCN1CC(=O)O)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
    2.1.5 Isomeric SMILES
    CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C1CN(CCN(CCN(CCN1CC(=O)O)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
    2.2 Other Identifiers
    2.2.1 UNII
    L0ND3981AG
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Gadoterate Meglumine

    2.3.2 Depositor-Supplied Synonyms

    1. Magnescope

    2. Meglumine Gadoterate (jan)

    3. Gadoterate Meglumine (usan)

    4. Gadoterate Meglumine [usan]

    5. Meglumine Gadoterate [jan]

    6. Magnescope (tn)

    7. Dotarem (tn)

    8. Schembl20420633

    9. Gadoterate Meglumine [vandf]

    10. Gadoterate Meglumine [usp-rs]

    11. Meglumine Gadoterate [who-dd]

    12. Ek-5504

    13. Gadoterate Meglumine [orange Book]

    14. P449

    15. P-449

    16. D03355

    17. Q27144071

    18. 2-[4,7-bis(carboxylatomethyl)-10-(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+);(2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol

    19. D-glucitol, 1-deoxy-1-(methylamino)-, (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetato(4-)-.kappa.n1,.kappa.n4,.kappa.n7,.kappa.n10,.kappa.o1,.kappa.o4,.kappa.o7,.kappa.o10)gadolinate(1-) (1:1)

    2.4 Create Date
    2006-07-28
    3 Chemical and Physical Properties
    Molecular Weight 753.9 g/mol
    Molecular Formula C23H42GdN5O13
    Hydrogen Bond Donor Count7
    Hydrogen Bond Acceptor Count18
    Rotatable Bond Count11
    Exact Mass754.20202 g/mol
    Monoisotopic Mass754.20202 g/mol
    Topological Polar Surface Area284 Ų
    Heavy Atom Count42
    Formal Charge0
    Complexity644
    Isotope Atom Count0
    Defined Atom Stereocenter Count4
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count3
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameDotarem
    PubMed HealthGadoterate (Injection)
    Drug ClassesDiagnostic Agent, Radiopharmaceutical Imaging
    Drug LabelDOTAREM (gadoterate meglumine) is a paramagnetic macrocyclic ionic contrast agent administered for magnetic resonance imaging. The chemical name for gadoterate meglumine is D-glucitol, 1-deoxy-1-(methylamino)-,[1,4,7,10-tetraazacyclododecane-1,4,7,10...
    Active IngredientGadoterate meglumine
    Dosage FormSolution
    RouteIntravenous
    Strength5.6535gm/15ml (376.9mg/ml); 3.769gm/10ml (376.9mg/ml); 37.69gm/100ml (376.9mg/ml); 7.538gm/20ml (376.9mg/ml)
    Market StatusPrescription
    CompanyGuerbet

    2 of 2  
    Drug NameDotarem
    PubMed HealthGadoterate (Injection)
    Drug ClassesDiagnostic Agent, Radiopharmaceutical Imaging
    Drug LabelDOTAREM (gadoterate meglumine) is a paramagnetic macrocyclic ionic contrast agent administered for magnetic resonance imaging. The chemical name for gadoterate meglumine is D-glucitol, 1-deoxy-1-(methylamino)-,[1,4,7,10-tetraazacyclododecane-1,4,7,10...
    Active IngredientGadoterate meglumine
    Dosage FormSolution
    RouteIntravenous
    Strength5.6535gm/15ml (376.9mg/ml); 3.769gm/10ml (376.9mg/ml); 37.69gm/100ml (376.9mg/ml); 7.538gm/20ml (376.9mg/ml)
    Market StatusPrescription
    CompanyGuerbet

    5 Pharmacology and Biochemistry
    5.1 MeSH Pharmacological Classification

    Contrast Media

    Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)